Method for constructing nasogastric tube indwelling injury New Zealand rabbit animal model
By simulating the nasogastric tube catheterization process on New Zealand rabbits, an animal model of nasogastric tube catheterization injury was established, which solved the problems of mucosal damage and inflammatory response during nasogastric tube catheterization, and provided a research basis for evaluation and reduction of damage. , realizes model construction with high success rate.
Patent Information
- Application Number
- CN202310533357.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-12
- Publication Date
- 2024-11-12
AI Technical Summary
The nasopharyngeal esophageal mucosa damage and inflammatory responses are often caused during nasopharyngeal esophageal tract placement, and there is a lack of effective animal models for damage evaluation and parameter impact studies, resulting in a high incidence of complications for catheterization.
New Zealand rabbits were used as animal model, and the nasogastric tubes made of silicone rubber or polyurethane materials were inserted into the nasal and gastric tubes made of silicone rubber or polyurethane materials after anesthesia and fixation, and the nasopharyngeal esophagus were observed and measured according to the standard clinical catheterization procedure. Injury and inflammatory factors, simulate the clinical catheterization process and perform histological analysis.
A New Zealand rabbit animal model for nasogastric tube catheterization injury was successfully established, which simulated the clinical catheterization process, provided the basis for evaluating and reducing damage plans. It is simple to operate and has a high success rate, and can quantify the degree of catheterization injury.
Smart Images

Figure CN118924469A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of animal models, and in particular to a method for constructing a New Zealand rabbit animal model of nasogastric tube intubation injury. Background Art
[0002] Nasogastric tube placement is a routine nursing measure used to solve digestive tract problems in clinical practice. It is widely used in the care of patients with gastrointestinal bleeding, anorexia nervosa, intestinal dysfunction, and perioperative nutritional management. However, during the placement of the nasogastric tube, the friction and mechanical stimulation of the tube wall on the nasopharyngeal esophageal mucosa are large, which can easily induce nasopharyngeal esophageal mucosal damage and secondary inflammatory reactions such as epistaxis, nasal septum trauma, pharyngeal mucosal ulcers, and esophageal submucosal edema. This not only causes discomfort symptoms such as pain in patients, but also may aggravate the symptoms of primary cardiovascular and cerebrovascular diseases, which is not conducive to patient recovery. Statistical results show that the incidence of tube placement complications in patients with nasogastric tube placement is as high as 10%, which is a clinical problem that needs to be solved urgently. However, in clinical work, it is impossible to obtain normal tissue specimens for tube placement injury evaluation, and it is impossible to carry out research on the influence of tube placement parameters such as model and material on the degree of injury and explore solutions to reduce tube placement injury. Therefore, it is of great significance to establish an animal model of nasogastric tube placement injury.
[0003] At present, there is no report on the establishment of an animal model of nasogastric tube placement injury. Although patent CN 114271235A inserts a modified gastric tube into an experimental rabbit to construct autologous gastric acid reflux, it does not involve tube placement injury. New Zealand rabbits are monogastric mammals with a moderate body size. They are more convenient than other animals in terms of model making and dissection, and the experimental cost is also lower. They are the preferred animals for preparing an animal model of nasogastric tube placement injury. Therefore, the present invention provides a method for constructing a New Zealand rabbit animal model of nasogastric tube placement injury. Summary of the invention
[0004] The purpose of the present invention is to provide a method for constructing a New Zealand rabbit animal model of nasogastric tube placement injury with strong operability, high success rate and the ability to effectively simulate the clinical nasogastric tube placement process and injury conditions, thereby laying a foundation for the subsequent evaluation of nasogastric tube placement injury, how placement parameters affect placement injury and the development of a plan to reduce placement injury.
[0005] The technical solution of the present invention for achieving the above-mentioned object is as follows: A method for constructing a New Zealand rabbit animal model of nasogastric tube intubation injury comprises the following steps: 1) Anesthetize and fix the New Zealand rabbits: The experimental rabbits fasted for 12 hours before catheterization, and sodium pentobarbital was injected into the ear vein for general anesthesia. Then the experimental rabbits were guided to lie in a supine position and fixed in a preset position; 2) Place a nasogastric tube: According to the standard clinical catheterization process, the gastric tube was slowly inserted through the nose, and gastric juice was aspirated through the nasogastric tube with a syringe to check whether the nasogastric tube was successfully inserted into the stomach. The external gastric tube was sutured and fixed to the lateral nasal cartilage on the same side. At the same time, the catheterization parameters were recorded during the entire intubation process; 3) Awaken the New Zealand rabbits; 4) Determine the relevant indicators of the animal model: After a certain period of catheterization, the nasogastric tube was slowly removed, and the nasopharyngeal esophageal injury was observed using a laryngoscope. Then the experimental rabbits were killed and the nasopharyngeal mucosa was obtained for histological staining and inflammatory factor determination.
[0006] The material of the nasogastric tube is silicone rubber or polyurethane.
[0007] The models of the nasogastric tube are No. 6, No. 8, and No. 10.
[0008] The catheterization parameters include catheterization time and the number of times required for successful catheterization.
[0009] The retention time is 1-90 hours.
[0010] The laryngoscope blade has a size of 100 mm.
[0011] The histological staining is HE staining.
[0012] The inflammatory factors are IL-1b, IL-6, IL-10 and TNF-α. BRIEF DESCRIPTION OF THE DRAWINGS
[0013] Figure 1 X-ray image of Example 21.
[0014] Figure 2 Laryngoscope pictures of Example 5, Example 21 and Comparative Example.
[0015] Figure 3 HE staining pictures of Example 5, Example 21 and Comparative Example.
[0016] Figure 4 The inflammatory factors of Example 5, Example 9, Example 13, Example 17, Example 21 and the comparative example. DETAILED DESCRIPTION
[0017] The examples given below are specific descriptions of the present invention. It is necessary to point out that the following examples are only used to further illustrate the present invention and cannot be understood as limiting the scope of protection of the present invention. Examples 1-3
[0018] A method for constructing an animal model of nasogastric tube placement injury of the present invention comprises the following steps: 1) Anesthetize and fix New Zealand rabbits: The experimental rabbits fasted for 12 hours before catheterization, and sodium pentobarbital was injected into the ear vein for general anesthesia. Then, the experimental rabbits were guided to lie in a supine position and fixed in a preset position; 2) Placement of nasogastric tube: According to the standard clinical catheterization process, the gastric tube was slowly inserted through the nose. When the nasogastric tube was inserted to 35 cm, it was stopped. Gastric juice was aspirated through the nasogastric tube with a syringe to check whether the nasogastric tube was successfully inserted into the stomach. The external gastric tube was sutured and fixed to the lateral nasal cartilage on the same side. At the same time, the catheterization parameters were recorded throughout the intubation process. The model and indwelling time of the nasogastric tube are shown in Table 1; 3) Awakening of experimental rabbits; 4) Verification of relevant indicators of the animal model: After a certain period of catheterization, the nasogastric tube was slowly removed, and the nasopharyngeal esophageal injury was observed using a laryngoscope. Then, the experimental rabbits were killed, and the nasopharyngeal mucosa was taken for HE staining and inflammatory factors (IL-1b, IL-6, IL-10 and TNF-α) determination. Example 4-21
[0019] A method for constructing an animal model of nasogastric tube placement injury of the present invention comprises the following steps: 1) Anesthetize and fix New Zealand rabbits: The experimental rabbits fasted for 12 hours before tube placement, and sodium pentobarbital was injected into the ear vein for general anesthesia. Then, the experimental rabbits were guided to lie supine and fixed in the preset position; 2) Placement of nasogastric tube: An experienced nurse slowly inserted a No. 6 nasogastric tube through the nose according to the standard clinical tube placement process. When the nasogastric tube was inserted to 35 cm, the tube was stopped and gastric juice was aspirated through the nasogastric tube with a syringe to check whether the nasogastric tube was successfully inserted into the stomach. The external gastric tube was sutured and fixed to the ipsilateral nasal cartilage. The retention time is shown in Table 1; 3) Awakening of experimental rabbits; 4) Verification of relevant indicators of the animal model: After a certain period of tube placement, the nasogastric tube was slowly removed, and the nasopharyngeal esophageal injury was observed using a laryngoscope. Then, the experimental rabbits were killed, and the nasopharyngeal mucosa was obtained for HE staining and determination of inflammatory factors (IL-1b, IL-6, IL-10 and TNF-α). Comparative Example
[0020] The New Zealand rabbits were not treated in any way to obtain a blank control group.
[0021] Table 1 Nasogastric tube type and indwelling time Example Nasogastric tube model Retention time (h) 1 No. 6 24 2 No. 8 24 3 No. 10 24 4 No. 6 5 5 No. 6 10 6 No. 6 15 7 No. 6 20 8 No. 6 25 9 No. 6 30 10 No. 6 35 11 No. 6 40 12 No. 6 45 13 No. 6 50 14 No. 6 55 15 No. 6 60 16 No. 6 65 17 No. 6 70 18 No. 6 75 19 No. 6 80 20 No. 6 85 21 No. 6 90 Table 2 Nasogastric tube placement parameters Example Nasogastric tube model Time required for catheterization (s) Number of successful catheterizations 1 No. 6 41.82±9.33 2±1 2 No. 8 75.13±15.65 5±1 3 No. 10 Unable to intubate Unable to intubate Table 3 Inflammatory factors of Examples 4, 6-8, 10-12, 14-16, 18-20 Example IL-1b (pg / ml) IL-6 (pg / ml) IL-10 (pg / ml) TNF-α(pg / ml) 4 4.1±1.1 4.1±1.2 39.1±0.9 11.2±0.7 6 4.6±0.8 4.8±0.8 40.9±1.3 12.1±0.9 7 4.7±1.3 4.9±1.5 41.5±1.4 12.6±0.6 8 4.9±1.5 5.1±1.3 42.3±1.5 12.9±1.5 10 5.1±0.8 5.6±1.7 43.4±1.1 13.5±1.2 11 5.3±0.9 5.8±0.7 44.3±0.7 13.8±0.9 12 5.6±0.6 6.2±1.1 45.1±0.9 14.3±0.5 14 5.7±1.2 6.5±0.5 45.8±0.4 14.9±1.1 15 5.9±1.3 6.6±0.2 46.7±1.1 15.1±0.8 16 6.2±0.7 6.9±1.1 47.1±1.5 15.2±0.6 18 6.5±1.5 7.2±0.8 47.9±1.2 15.5±0.8 19 6.9±1.1 7.4±1.2 49.1±0.6 15.8±1.2 20 7.6±0.5 7.8±1.5 50.3±0.7 15.9±1.7 The following text describes the injury caused by nasogastric tube placement in the animal model constructed by the method for constructing a New Zealand rabbit animal model of nasogastric tube placement injury of the present invention.
[0022] The New Zealand rabbit animal model of nasogastric tube injury of the present invention ( Figure 1 ), visual flexible laryngoscope, HE staining and ELISA kit were used to characterize the injuries caused by nasogastric tube placement.
[0023] The following text further describes Examples 5, 9, 13, 17, 21 and the comparative examples in conjunction with the accompanying drawings. As for the results of inflammatory factors in each example other than Examples 1-3, 5, 9, 13, 17, 21 and the comparative examples, please see Table 3 for details. For the sake of simplicity, the relevant drawings of the other examples and comparative examples other than Examples 5, 9, 13, 17, 21 and the comparative examples are omitted herein.
[0024] In order to determine the appropriate nasogastric tube model, No. 6, No. 8, and No. 10 were selected for nasogastric tube intubation experiments and the corresponding intubation parameters were recorded. The results are shown in Table 2. The time required for intubation of No. 6 nasogastric tube and the number of times required for successful intubation were 41.82±9.33 s and 2±1 times, respectively, which were significantly less than No. 8 nasogastric tube. No. 10 nasogastric tube could not be successfully intubated.
[0025] In order to visually observe the damage caused by nasogastric tube placement, the rabbit's nasal cavity and nasopharynx were observed using a visual flexible laryngoscope. Figure 2 Compared with the comparative example, obvious mucosal edema and sporadic bleeding occurred in the nasal cavity and nasopharynx in Examples 5 and 21. As the indwelling time increased, Example 21 showed more severe catheter injury than Example 5.
[0026] To further observe the damage caused by catheterization, the superior turbinate and nasal septum mucosa of the rabbits were examined using HE staining. Figure 3 It can be seen that compared with the comparative example, the nasal mucosal epithelial cells of Examples 5 and 21 were significantly damaged and shed, and a large number of inflammatory cells including lymphocytes, neutrophils and eosinophils infiltrated.
[0027] To quantify the degree of catheter injury, inflammatory factors in the nasal mucosa were measured using an ELISA kit, and the results are shown in Table 3. As the indwelling time increased, the levels of inflammatory factors gradually increased. Figure 4 The levels of inflammatory factors in Examples 5, 9, 13, 17, and 21 and the comparative example were further compared. Compared with the comparative example, the level of inflammatory factors in the nasal mucosa was significantly increased after the nasogastric tube was placed, and the prolonged placement time would increase the damage to the tube.
[0028] The present invention has for the first time established a New Zealand rabbit animal model of nasogastric tube placement injury. The construction method provided can simulate the clinical nasogastric tube placement process, laying a foundation for conducting multi-scale tube placement injury evaluation, exploring the influence of tube placement parameters on tube placement injury, and exploring solutions to reduce tube placement injury. At the same time, the construction method is simple to operate and has a high success rate.
[0029] The present invention has been described in detail above with reference to the embodiments, which are illustrative rather than restrictive. Changes and modifications without departing from the overall concept of the present invention are within the protection scope of the present invention.
Claims
1. A method for constructing a New Zealand rabbit animal model of nasogastric tube injury, characterized in that: The following steps are involved: 1) Anesthetize and fix the New Zealand rabbits: The experimental rabbits were fasted for 12 hours before catheterization, and sodium pentobarbital was injected into the ear vein for general anesthesia. Then the experimental rabbits were guided to lie in a supine position and fixed in a preset position; 2) Place a nasogastric tube: According to the standard clinical catheterization process, the gastric tube was slowly inserted through the nose, and gastric juice was aspirated through the nasogastric tube with a syringe to check whether the nasogastric tube was successfully inserted into the stomach. The external gastric tube was sutured and fixed to the lateral nasal cartilage on the same side; 3) Awaken the New Zealand rabbits; 4) Determine the relevant indicators of the animal model: After a certain period of catheterization, the nasogastric tube was slowly removed, and the nasopharyngeal esophageal injury was observed with a laryngoscope. Then the experimental rabbits were killed, and the nasopharyngeal mucosa was obtained for histological staining and inflammatory factor determination.
2. The preparation method according to claim 1, characterized in that: The material of the nasogastric tube is silicone rubber or polyurethane.
3. The preparation method according to claim 1, characterized in that: The models of the nasogastric tube are No. 6, No. 8, and No.
10.
4. The preparation method according to claim 1, characterized in that: The catheterization parameters include catheterization time and the number of times required for successful catheterization.
5. The preparation method according to claim 1, characterized in that: The retention time is 1-90 hours.
6. The preparation method according to claim 1, characterized in that: The laryngoscope blade has a size of 100 mm.
7. The preparation method according to claim 1, characterized in that: The histological staining is hematoxylin-eosin (HE) staining.
8. The preparation method according to claim 1, characterized in that: The inflammatory factors are interleukin-1b (IL-1b), interleukin-6 (IL-6), interleukin 10 (IL-10) and tumor necrosis factor-α (TNF-α).
